Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn the key money moves successful people make, from goal setting to conscious spending and informed investing that build lasting wealth.
12,910 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
As Ardent Health closes 2025, the Q4 results shed light on margins, volumes, and balance-sheet health. This analysis ...
Bitcoin stays above the $70,000 mark as ETF inflows bolster the floor, even as major investors chase Layer 2 presales...
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
NIO and LI AUTO report divergent Q3 2025 results: NIO accelerates with a multi-brand push, while LI AUTO trims extend...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
Salesforce plans up to $25 billion in debt to fund an accelerated share repurchase that would buy back roughly 14% of...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
Investors are weighing Oklo's unique nuclear energy model against a bumpy ride in its stock. This guide breaks down t...
U.S.-China talks open in Paris as officials prepare for a high-stakes Xi summit. The discussions, led by bessent lead...
Investors eye Hewlett Packard Enterprise’s 2026 earnings call for guidance on AI demand, GreenLake growth, and capita...